- Lobbying
- amerisourcebergen AND corporation
Lobbying Arrangements Results for 'Amerisourcebergen Corporation'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Various healthcare proposals. |
AmerisourceBergen Corporation
|
Vorys Advisors, LLC | |||
Details Promote legislative and regulatory solutions to ensure patient access to community based care |
AmerisourceBergen Corporation
|
VENN STRATEGIES, LLC | |||
Details Issues related to drug supply chains; generic drug shortage. |
AmerisourceBergen Corporation
|
ANWAY LONG GROUP | |||
Details Policies impacting the national stockpile H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act Medicare sequestration Issues impacting drug pricing and reimbursement |
AmerisourceBergen Corporation
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Issues related to supply chain management and drug pricing |
Cencora, Inc. (Formerly AmerisourceBergenCorporation)
|
OXFORD STRATEGIES | |||
Details Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issue... |
Cencora, Inc. (Formerly AmerisourceBergen Corporation)
|
TCH Group, LLC | |||
Details Medicare and Medicaid legislative advice |
AmerisourceBergen Corporation
|
LAW OFFICES OF FREDERICK H. GRAEFE, PLLC | |||
Details H.R. 1392, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pa... |
AmerisourceBergen Corporation
|
CAUTHEN FORBES & WILLIAMS | |||
Details Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transpare... |
Cencora fka AmerisourceBergen Corporation
|
Horizon Government Affairs | |||
Details medicare and medicaid legislative advice |
AmerisourceBergen Corporation
|
LAW OFFICES OF FREDERICK H. GRAEFE, PLLC | |||
Details Medicare Part B Reimbursement. Average Sales Price (ASP). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees The Equi... |
Cencora, Inc.
|
in-house lobbying | |||
Details General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals |
AmerisourceBergen Corporation
|
Lincoln Policy Group | |||
Details Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration ... |
AmerisourceBergen Corporation
|
WALTER CONSULTING | |||
Details Recognizing pharmacists as providers within Medicare COVID-19 response; H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); H.R. 2670-National Defense Authorization Act For Fiscal Y... |
Cencora, Inc. (Formerly AmerisourceBergen Corporation)
|
Ballard Spahr LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. |
AmerisourceBergen Corporation
Health care interests |
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare part B and sequestration. Issues pertaining to Federal Drug Pedigree and Drug Shortages. |
AmerisourceBergen Corporation
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from... |
AMERISOURCEBERGEN CORPORATION (Formerly "AmerisourceBergen Specialty Group")
|
Nossaman LLP (Formerly Nossaman LLP/O'Connor & Hannan) | |||
Details Legislative proposals related to prompt pay discounts for drugs and biologicals under Medicare Part B, including S. 733 and H.R. 905; federal policy regarding proposed changes to Medicare drug reim... |
AmerisourceBergen Corporation
|
Dow Lohnes Government Strategies LLC | |||
Details Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended ... |
AMERISOURCEBERGEN CORPORATION
|
Roberti Global (fka Roberti White, LLC) | |||
Details H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological... |
AMERISOURCEBERGEN CORPORATION
|
CAPITOL HEALTH GROUP, LLC | |||
Details Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles, including H.R. 405, the Essential Medicines Strategic Stockpile Act of 2023. Legislation that would perm... |
Cencora Inc. (formerly AmerisourceBergen Corporation)
|
Kountoupes Denham Carr & Reid, LLC | |||
Details Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers ... |
Cencora, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Ensuring access to vital pharmacist services. |
Future of Pharmacy Coalition
|
VENN STRATEGIES | |||
Details Advancing H.R.7213, Equitable Community Access to Pharmacist Services Act. |
Future of Pharmacy Coalition LLC
|
ALSTON & BIRD LLP |